Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A or B”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Early research (Phase 1)Study completedNCT01562587
What this trial is testing

Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 18
Early research (Phase 1)Looking for participantsNCT06349473
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

Who this might be right for
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC 31
Testing effectiveness (Phase 2)Study completedNCT00108758
What this trial is testing

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 23
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05662319
What this trial is testing

Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

Who this might be right for
Hemophilia
Sanofi 91
Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT03935334
What this trial is testing

Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A or B With Inhibitor
AryoGen Pharmed Co. 48
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Large-scale testing (Phase 3)Active Not RecruitingNCT04082429
What this trial is testing

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Who this might be right for
Haemophilia A Without InhibitorsHaemophilia B Without Inhibitors
Novo Nordisk A/S 156
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Jiangsu Gensciences lnc. 27
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Jiangsu Gensciences lnc. 24
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT00936312
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 200
Not applicableEnrolling By InvitationNCT06831734
What this trial is testing

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Who this might be right for
Haemophilia A, Haemophilia B
Novo Nordisk A/S 30
Load More Results